Research

Get the latest details on current events, medical progress, and therapies used by mesothelioma patients around the globe. Learn More.

Immune Systems | New Drugs | New Studies | Research | Treatments | Updates

Lymphoma Drug May Fight Mesothelioma, Too
ByAlex Strauss January 17, 2015March 25, 2019

A drug granted accelerated FDA approval for the treatment of lymphomas appears to kill some types mesothelioma cells, too. Cancer…

Read More Lymphoma Drug May Fight Mesothelioma, Too
Biomarkers | Chemotherapy | Diagnosis | Immune Systems | Research | Treatments | Updates

Mesothelioma Chemotherapy: Can Supplements Make it Safer?
ByAlex Strauss January 8, 2015March 25, 2019

Vitamin B12 and folic acid supplements are often given to mesothelioma patients who are on chemotherapy in an effort to…

Read More Mesothelioma Chemotherapy: Can Supplements Make it Safer?
Asia | International | Mesothelioma | New Drugs | New Studies | Research | Treatments | Updates

Experimental Drug May Offer “Brilliant Hope” for Mesothelioma Treatment
ByAlex Strauss January 6, 2015March 23, 2019

HUHS1015 is a newly-synthesized analogue (chemically similar compound) of the blood pressure drug naftopidil. In the U.S., naftopidil is sold…

Read More Experimental Drug May Offer “Brilliant Hope” for Mesothelioma Treatment
Chemotherapy | Multi-Modality Therapy | New Studies | Radiation Therapy | Research | Surgery | Treatments | Updates

Induction Therapies Improve Mesothelioma Surgery Outcomes
ByAlex Strauss December 31, 2014March 24, 2019

An induction therapy is the first in a series of therapeutic measures, which, in the case of mesothelioma, may include…

Read More Induction Therapies Improve Mesothelioma Surgery Outcomes
Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Mesothelioma Patients May Need Medication to Reduce Clot Risk
ByAlex Strauss December 20, 2014May 27, 2019

Researchers in Ankara, Turkey have just released a new study on the increased risk of thromboembolic events (TEEs) in patients…

Read More Mesothelioma Patients May Need Medication to Reduce Clot Risk
Asbestos | Genetics | Mesothelioma Breaking News | Research | Updates

Multi-Center Study Reveals “Genomic Basis” of Mesothelioma
ByAlex Strauss December 12, 2014March 25, 2019

Doctors with the Broad Institute of Harvard and MIT, the University of Hawaii Cancer Center, and the Departments of Cardiothoracic…

Read More Multi-Center Study Reveals “Genomic Basis” of Mesothelioma
Biomarkers | Diagnosis | Europe | Genetics | International | Research | Statistics | Updates

BAP1 Mutation Unlikely to Trigger Sporadic Mesothelioma
ByAlex Strauss December 8, 2014March 20, 2019

But researchers at the Clinic of Oncology at the University Hospital of Zurich and University Hospitals in Leuven, Belgium say…

Read More BAP1 Mutation Unlikely to Trigger Sporadic Mesothelioma
Asbestos | New Drugs | New Studies | Research | Treatments | Updates

Newly Approved Drug for Asbestosis-like Condition Now Being Tested for Mesothelioma
ByAlex Strauss December 2, 2014March 16, 2017

Following the recent FDA approval of a new drug for a form of lung scarring, researchers have begun testing the…

Read More Newly Approved Drug for Asbestosis-like Condition Now Being Tested for Mesothelioma
Asia | International | Mesothelioma | New Drugs | New Studies | Research | Treatments | Updates

Japanese Doctors Test Potential New Target for Mesothelioma Therapy
ByAlex Strauss November 28, 2014March 24, 2019

. Mesothelioma is a fast-growing and currently incurable cancer that occurs most often in people who have been exposed to…

Read More Japanese Doctors Test Potential New Target for Mesothelioma Therapy
New Drugs | New Studies | Research | Treatments | Updates

‘Tunnels’ Between Cells: A New Target for Mesothelioma Treatment?
ByAlex Strauss November 19, 2014July 9, 2019

Doctors with Memorial Sloan Kettering Cancer Center in New York and the University of Minnesota in Minneapolis have just released…

Read More ‘Tunnels’ Between Cells: A New Target for Mesothelioma Treatment?

1 (888) 378-1331

Research

Lymphoma Drug May Fight Mesothelioma, Too

Mesothelioma Chemotherapy: Can Supplements Make it Safer?

Experimental Drug May Offer “Brilliant Hope” for Mesothelioma Treatment

Induction Therapies Improve Mesothelioma Surgery Outcomes

Mesothelioma Patients May Need Medication to Reduce Clot Risk

Multi-Center Study Reveals “Genomic Basis” of Mesothelioma

BAP1 Mutation Unlikely to Trigger Sporadic Mesothelioma

Newly Approved Drug for Asbestosis-like Condition Now Being Tested for Mesothelioma

Japanese Doctors Test Potential New Target for Mesothelioma Therapy

‘Tunnels’ Between Cells: A New Target for Mesothelioma Treatment?

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES